Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOTULINUM TOXIN TYPE A vs BRIGATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOTULINUM TOXIN TYPE A vs BRIGATINIB: Safety Overview

Metric BOTULINUM TOXIN TYPE A BRIGATINIB
Total FAERS Reports 3,742 3,286
Deaths Reported 1,288 729
Death Rate 34.4% 22.2%
Hospitalizations 1,536 912
Average Patient Age 44.1 yrs 61.2 yrs
% Female Patients 78.8% 57.3%
FDA Approval Date N/A Apr 28, 2017
Manufacturer Evolus, Inc. Takeda Pharmaceuticals America, Inc.
Route INTRAMUSCULAR ORAL
Marketing Status N/A Prescription